Merck & Co. Will Manufacture J&J Vaccine, Other COVID-19 Medicines Under BARDA Deal

US Government Will Fund Up To $268.8m In Production Site Upgrades

 
• By Mandy Jackson
  
Some ampoules with ncov-2019 vaccine in a box
Merck & Co. will provide additional COVID-19 vaccine and treatment manufacturing capacity in the US under a new BARDA deal • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip